Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 2 |
GO:0016020 | membrane | 2 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: Q4Q729
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 147 | 151 | PF00656 | 0.586 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.421 |
CLV_PCSK_FUR_1 | 23 | 27 | PF00082 | 0.323 |
CLV_PCSK_KEX2_1 | 25 | 27 | PF00082 | 0.328 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.386 |
CLV_PCSK_PC1ET2_1 | 25 | 27 | PF00082 | 0.444 |
CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.472 |
DOC_MAPK_gen_1 | 23 | 33 | PF00069 | 0.349 |
LIG_14-3-3_CanoR_1 | 55 | 61 | PF00244 | 0.392 |
LIG_14-3-3_CanoR_1 | 68 | 76 | PF00244 | 0.469 |
LIG_APCC_ABBA_1 | 31 | 36 | PF00400 | 0.348 |
LIG_BRCT_BRCA1_1 | 53 | 57 | PF00533 | 0.480 |
LIG_BRCT_BRCA1_1 | 72 | 76 | PF00533 | 0.280 |
LIG_FHA_1 | 11 | 17 | PF00498 | 0.544 |
LIG_FHA_1 | 147 | 153 | PF00498 | 0.537 |
LIG_FHA_1 | 28 | 34 | PF00498 | 0.392 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.343 |
LIG_FHA_1 | 64 | 70 | PF00498 | 0.386 |
LIG_FHA_2 | 145 | 151 | PF00498 | 0.583 |
LIG_FHA_2 | 99 | 105 | PF00498 | 0.537 |
LIG_LIR_Gen_1 | 100 | 111 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 100 | 106 | PF02991 | 0.304 |
LIG_LIR_Nem_3 | 85 | 91 | PF02991 | 0.423 |
LIG_MYND_1 | 118 | 122 | PF01753 | 0.479 |
LIG_PDZ_Class_2 | 151 | 156 | PF00595 | 0.562 |
LIG_SH2_STAP1 | 58 | 62 | PF00017 | 0.354 |
LIG_SH2_STAT3 | 64 | 67 | PF00017 | 0.496 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.351 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.343 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.342 |
LIG_SUMO_SIM_anti_2 | 149 | 156 | PF11976 | 0.530 |
MOD_CK1_1 | 70 | 76 | PF00069 | 0.394 |
MOD_CK2_1 | 98 | 104 | PF00069 | 0.535 |
MOD_GlcNHglycan | 76 | 79 | PF01048 | 0.390 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.630 |
MOD_GSK3_1 | 142 | 149 | PF00069 | 0.707 |
MOD_GSK3_1 | 63 | 70 | PF00069 | 0.441 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.530 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.374 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.645 |
MOD_NEK2_1 | 129 | 134 | PF00069 | 0.505 |
MOD_NEK2_1 | 76 | 81 | PF00069 | 0.374 |
MOD_PIKK_1 | 63 | 69 | PF00454 | 0.358 |
MOD_PKA_2 | 27 | 33 | PF00069 | 0.478 |
MOD_PKA_2 | 67 | 73 | PF00069 | 0.485 |
MOD_Plk_1 | 70 | 76 | PF00069 | 0.392 |
MOD_Plk_2-3 | 98 | 104 | PF00069 | 0.473 |
MOD_Plk_4 | 71 | 77 | PF00069 | 0.373 |
MOD_Plk_4 | 98 | 104 | PF00069 | 0.578 |
TRG_ENDOCYTIC_2 | 21 | 24 | PF00928 | 0.362 |
TRG_ENDOCYTIC_2 | 34 | 37 | PF00928 | 0.386 |
TRG_ER_diArg_1 | 26 | 29 | PF00400 | 0.382 |
TRG_NLS_MonoExtC_3 | 24 | 29 | PF00514 | 0.464 |
TRG_NLS_MonoExtN_4 | 23 | 29 | PF00514 | 0.462 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5G5 | Leptomonas seymouri | 72% | 100% |
A0A3Q8IS54 | Leishmania donovani | 96% | 100% |
A0A3R7LZP3 | Trypanosoma rangeli | 51% | 99% |
A4HIJ8 | Leishmania braziliensis | 74% | 100% |
A4I5U2 | Leishmania infantum | 96% | 100% |
C9ZR62 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 98% |
E9B137 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
V5DP06 | Trypanosoma cruzi | 48% | 99% |